View Older Stories View More Recent Stories

Oct 22, 2019 05:08PM Biogen, Eisai revive plans for Alzheimer's drug, surprising market

Oct 22, 2019 07:32AM Biogen (BIIB) News 'Somewhat Astonishing', Shares Could Trade Back Toward Low-$300s - RBC

Sep 16, 2019 01:51PM Biogen (BIIB) BG00011 Just Stopped For Toxicity, But Low Impact - RBC

Sep 6, 2019 07:31AM Biogen (BIIB) Competitor Likely to Post Pivotal Results Next Week - RBC Capital

Jul 24, 2019 06:44AM Biogen (BIIB) PT Raised to $242 at RBC Capital

Apr 25, 2019 06:38AM Biogen (BIIB) PT Lowered to $234 at RBC Capital

Mar 25, 2019 07:12AM Biogen (BIIB) PT Slashed At RBC On Alzheimer's Prospects

Feb 12, 2019 06:48AM Complex Setup Keeps RBC on Sidelines with Biogen (BIIB); PT Lowered to $318

Jan 30, 2019 06:25AM Biogen (BIIB) PT Lowered to $337 at RBC Capital

Jan 3, 2019 03:59PM Bristol-Myers/Celgene Deal Likely Kicks Off 'Big Year' In Biopharma M&A - RBC

Nov 26, 2018 07:03AM Biogen (BIIB) PT Lowered to $338 at RBC Capital on Underappreciated Tecfidera IP Risk

Oct 24, 2018 06:55AM Biogen (BIIB) PT Raised to $364 at RBC Capital

Jul 25, 2018 07:44AM Biogen (BIIB) PT Raised to $357 at RBC Capital

Jul 6, 2018 06:59AM Biogen (BIIB): Positive Alzheimer's Data Likely A Big Catalyst - RBC

May 31, 2018 03:56PM RBC Positive on Biogen (BIIB) Karp Hire Amid Partnerships/M&A Potential

May 31, 2018 01:42PM RBC Sees Positive Read-Through to Alder Biopharm (ALDR) from Allergan, Biogen Developments

May 15, 2018 07:56AM Vertex Pharma (VRTX), Alexion Pharma (ALXN) Least Impacted from Trump Drug Policies - RBC

Apr 25, 2018 07:43AM Biogen (BIIB) PT Lowered to $311 at RBC Capital

Apr 18, 2018 01:59PM Biogen (BIIB) Missed Out on AveXis (AVXS) But Well-Positioned for Substantial Acquisition - RBC

Jan 25, 2018 09:30AM Pre-Open Movers 01/25: (DLB) (VAR) (MKC) Higher; (CFMS) (OCUL) (NWL) Lower (more...)

Sep 15, 2017 02:20AM RBC Capital Starts Biogen (BIIB) at Sector Perform

Feb 15, 2017 05:29PM Biogen to Present at the 2017 RBC Capital Markets Global Healthcare Conference

Dec 6, 2016 07:05AM Trump's corporate tax holiday could spur pharma M&A

Sep 28, 2016 09:10AM Pre-Open Stock Movers 09/28: (SEED) (AVXL) (ATHX) Higher; (GALT) (TPX) (SONC) Lower (more...)

Sep 20, 2016 10:32AM Allergan pays top dollar for 'stepping stones' from neurology to dermatology

Sep 16, 2016 04:52PM Perrigo explores sale of royalties of drug Tysabri: sources

Aug 2, 2016 03:41PM Biogen (BIIB) Could Be Worth $375-475/Share in a Takeover - RBC Capital's Yee

Jul 28, 2016 01:53PM U.S. biotech stocks win back investors in big July run

Jun 29, 2016 10:23AM Notable Analyst Rating Changes 6/29: (DYN) (CNC) (DAR) Upgraded; (HAR) (ESPR) (ZION) Downgraded

Apr 4, 2016 01:52PM Biotech Seen Grinding Higher, Says RBC Capital (IBB)

Oct 21, 2015 09:22AM RBC Comments on Bull/Bear Case on Biogen (BIIB) Following Q3 Results

Oct 21, 2015 07:45AM Biogen to cut 11 percent of staff, cancel some drug programs; stock jumps

Oct 8, 2015 03:19PM RBC Affirms Biogen (BIIB) at 'Outperform'; Roche's RRMS, PPMS Data Expected, But More Details Needed

Oct 7, 2015 02:31PM FWP Inference Case Change Doesn't Impact Fundamental Thesis on Biogen (BIIB); RBC Keeps at 'Outperform'

Aug 25, 2015 10:49AM Analyst Touches on Read Through from Dismissal of Acorda (ACOR) IPR (BIIB) (CELG)

Aug 11, 2015 10:19AM Notable Analyst Rating Changes 8/11: (ADBE) (RAX) (VZ) Upgraded; (AMAT) (KMT) (XON) Downgraded

Apr 15, 2015 09:31AM Pre-Open Stock Movers 04/15: (MCP) (CLSN) (INTC) Higher; (WLT) (PCP) (STWD) Lower (more...)

Mar 20, 2015 07:01AM Biogen (BIIB) BIIB-037 Data Shows Strong Efficacy, Very Good Safety, Says RBC

Feb 11, 2015 07:57AM Acorda (ACOR) IPR Patent Challenge Seen as Near-Term Overhang; RBC Maintains Outperform Rating

Jan 30, 2015 09:30AM Pre-Open Stock Movers 1/30: (BAMM) (ICPT) (AMZN) Higher; (GENE) (DECK) (ALGN) Lower (more...)

Dec 19, 2014 08:15AM Biogen (BIIB) Trades Lower After Roche (RHHBY) Alzheimer's Trial Halted; RBC Comments

Dec 2, 2014 10:02AM RBC Comments on Biogen (BIIB) Announcement to Move BIIB-037 to Phase 3 in Alzheimer's

Oct 22, 2014 01:27PM RBC Capital Comments on Biogen (BIIB) and Tecfidera PML Case; Analyst Maintains Outperform Rating

Oct 13, 2014 03:45PM RBC Capital Comments on Biotechs' Irish Tax Strategies; Gilead May See Modest EPS Impact (GILD) (AMGN)

Dec 20, 2013 08:59AM Biogen (BIIB) Price Target Raised to $325 at RBC Capital

Sep 9, 2013 09:36AM Pre-Open Stock Movers 9/9: (MOLX) (UNIS) (ISIS) Higher; (BIOD) (HSOL) (SCTY) Lower (more...)

Jun 14, 2013 12:50PM Biogen (BIIB) Might Buy Remaining Interest in Tysabri from Elan (ELN)

Jun 12, 2013 10:45AM Notable Analyst Rating Changes 06/12: (HMA) (AMAT) (RVBD) Upgraded; (BIIB) (LM) (USB) Downgraded

Apr 9, 2013 07:11AM RBC Capital Raises PT on Biogen (BIIB) to $215

Nov 21, 2012 10:27AM Notable Analyst Rating Changes 11/21: (PENN) (THOR) (SKX) Upgraded; (HTWR) (EV) (ICA) Downgraded

View More Recent Stories View Older Stories